# Decision Aid for Therapeutic Options In Sickle Cell Disease

> **NCT02326597** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 134 (actual)

## Conditions studied

- Sickle Cell Disease
- Sickle Cell Anemia
- Hemoglobin SS
- Hemoglobin SC
- Hemoglobin Beta Thalassemia

## Interventions

- **OTHER:** Decision Aid Tool
- **OTHER:** Standard Practice

## Key facts

- **NCT ID:** NCT02326597
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-04-17
- **Final completion:** 2017-04-17
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02326597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02326597, "Decision Aid for Therapeutic Options In Sickle Cell Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02326597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*